CELL REP 润色咨询

Cell Reports

出版年份：暂无数据 年文章数：10575 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：2.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216879, encodeId=fddc22168e9e0, content=投了一次，1天拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Thu Jul 25 21:54:18 CST 2024, time=2024-07-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：molecular biology<br>经验分享：难度不低，影响因子不高，不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿，今年1月接收，历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向：肠道微生物与宿主互作<br>经验分享：12月16号投的，23号under review，今天2月14号了，快2个月了，还没有消息，各位一般一审多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向：肿瘤<br>经验分享：文章质量很好，不明白为什么一直上不去10呢？难道是不怎么发综述吗？很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢，编辑态度很好，review意见专业，根据我的经验这个期刊算不上水刊，而且在国外认可度还不错，毕竟不靠发review拉分，唯一的就是版面费不便宜，cell press旗下，看好未来！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省)]
    2022-06-02 cindichaw

    年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。

    5

    展开5条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216879, encodeId=fddc22168e9e0, content=投了一次，1天拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Thu Jul 25 21:54:18 CST 2024, time=2024-07-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：molecular biology<br>经验分享：难度不低，影响因子不高，不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿，今年1月接收，历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向：肠道微生物与宿主互作<br>经验分享：12月16号投的，23号under review，今天2月14号了，快2个月了，还没有消息，各位一般一审多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向：肿瘤<br>经验分享：文章质量很好，不明白为什么一直上不去10呢？难道是不怎么发综述吗？很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢，编辑态度很好，review意见专业，根据我的经验这个期刊算不上水刊，而且在国外认可度还不错，毕竟不靠发review拉分，唯一的就是版面费不便宜，cell press旗下，看好未来！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省)]
    2024-07-25 pello11 来自北京

    投了一次，1天拒

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216879, encodeId=fddc22168e9e0, content=投了一次，1天拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Thu Jul 25 21:54:18 CST 2024, time=2024-07-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：molecular biology<br>经验分享：难度不低，影响因子不高，不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿，今年1月接收，历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向：肠道微生物与宿主互作<br>经验分享：12月16号投的，23号under review，今天2月14号了，快2个月了，还没有消息，各位一般一审多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向：肿瘤<br>经验分享：文章质量很好，不明白为什么一直上不去10呢？难道是不怎么发综述吗？很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢，编辑态度很好，review意见专业，根据我的经验这个期刊算不上水刊，而且在国外认可度还不错，毕竟不靠发review拉分，唯一的就是版面费不便宜，cell press旗下，看好未来！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省)]
    2022-03-09 hppv587

    二审一个月了还没消息

    16

    展开16条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216879, encodeId=fddc22168e9e0, content=投了一次，1天拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Thu Jul 25 21:54:18 CST 2024, time=2024-07-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：molecular biology<br>经验分享：难度不低，影响因子不高，不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿，今年1月接收，历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向：肠道微生物与宿主互作<br>经验分享：12月16号投的，23号under review，今天2月14号了，快2个月了，还没有消息，各位一般一审多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向：肿瘤<br>经验分享：文章质量很好，不明白为什么一直上不去10呢？难道是不怎么发综述吗？很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢，编辑态度很好，review意见专业，根据我的经验这个期刊算不上水刊，而且在国外认可度还不错，毕竟不靠发review拉分，唯一的就是版面费不便宜，cell press旗下，看好未来！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省)]
    2024-02-07 黑鬼儿 来自河北省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：molecular biology
    经验分享：难度不低，影响因子不高，不划算

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216879, encodeId=fddc22168e9e0, content=投了一次，1天拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Thu Jul 25 21:54:18 CST 2024, time=2024-07-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：molecular biology<br>经验分享：难度不低，影响因子不高，不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿，今年1月接收，历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向：肠道微生物与宿主互作<br>经验分享：12月16号投的，23号under review，今天2月14号了，快2个月了，还没有消息，各位一般一审多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向：肿瘤<br>经验分享：文章质量很好，不明白为什么一直上不去10呢？难道是不怎么发综述吗？很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢，编辑态度很好，review意见专业，根据我的经验这个期刊算不上水刊，而且在国外认可度还不错，毕竟不靠发review拉分，唯一的就是版面费不便宜，cell press旗下，看好未来！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省)]
    2024-01-22 ms2000001775137343 来自安徽省

    6月投稿，今年1月接收，历时7个月

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216879, encodeId=fddc22168e9e0, content=投了一次，1天拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Thu Jul 25 21:54:18 CST 2024, time=2024-07-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：molecular biology<br>经验分享：难度不低，影响因子不高，不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿，今年1月接收，历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向：肠道微生物与宿主互作<br>经验分享：12月16号投的，23号under review，今天2月14号了，快2个月了，还没有消息，各位一般一审多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向：肿瘤<br>经验分享：文章质量很好，不明白为什么一直上不去10呢？难道是不怎么发综述吗？很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢，编辑态度很好，review意见专业，根据我的经验这个期刊算不上水刊，而且在国外认可度还不错，毕竟不靠发review拉分，唯一的就是版面费不便宜，cell press旗下，看好未来！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省)]
    2024-01-17 ms9000001460504456 来自广东省

    请问今年影响因子能涨吗？

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216879, encodeId=fddc22168e9e0, content=投了一次，1天拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Thu Jul 25 21:54:18 CST 2024, time=2024-07-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：molecular biology<br>经验分享：难度不低，影响因子不高，不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿，今年1月接收，历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向：肠道微生物与宿主互作<br>经验分享：12月16号投的，23号under review，今天2月14号了，快2个月了，还没有消息，各位一般一审多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向：肿瘤<br>经验分享：文章质量很好，不明白为什么一直上不去10呢？难道是不怎么发综述吗？很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢，编辑态度很好，review意见专业，根据我的经验这个期刊算不上水刊，而且在国外认可度还不错，毕竟不靠发review拉分，唯一的就是版面费不便宜，cell press旗下，看好未来！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省)]
    2023-02-14 朋友一场 来自北京

    偏重的研究方向：肠道微生物与宿主互作
    经验分享：12月16号投的，23号under review，今天2月14号了，快2个月了，还没有消息，各位一般一审多久呀？

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216879, encodeId=fddc22168e9e0, content=投了一次，1天拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Thu Jul 25 21:54:18 CST 2024, time=2024-07-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：molecular biology<br>经验分享：难度不低，影响因子不高，不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿，今年1月接收，历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向：肠道微生物与宿主互作<br>经验分享：12月16号投的，23号under review，今天2月14号了，快2个月了，还没有消息，各位一般一审多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向：肿瘤<br>经验分享：文章质量很好，不明白为什么一直上不去10呢？难道是不怎么发综述吗？很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢，编辑态度很好，review意见专业，根据我的经验这个期刊算不上水刊，而且在国外认可度还不错，毕竟不靠发review拉分，唯一的就是版面费不便宜，cell press旗下，看好未来！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省)]
    2023-07-13 poiju 来自上海

    偏重的研究方向：肿瘤
    经验分享：文章质量很好，不明白为什么一直上不去10呢？难道是不怎么发综述吗？很多文章明显比有的10+期刊还好😅

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216879, encodeId=fddc22168e9e0, content=投了一次，1天拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Thu Jul 25 21:54:18 CST 2024, time=2024-07-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：molecular biology<br>经验分享：难度不低，影响因子不高，不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿，今年1月接收，历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向：肠道微生物与宿主互作<br>经验分享：12月16号投的，23号under review，今天2月14号了，快2个月了，还没有消息，各位一般一审多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向：肿瘤<br>经验分享：文章质量很好，不明白为什么一直上不去10呢？难道是不怎么发综述吗？很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢，编辑态度很好，review意见专业，根据我的经验这个期刊算不上水刊，而且在国外认可度还不错，毕竟不靠发review拉分，唯一的就是版面费不便宜，cell press旗下，看好未来！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省)]
    2022-11-01 苦逼科研仔

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：20220428 submitted
    20220506 under review
    20220622 all reviews complete
    20220623 major revision
    20220822 revised
    20221018 pre-accept
    20221101 accept
    整个投稿过程不快不慢，编辑态度很好，review意见专业，根据我的经验这个期刊算不上水刊，而且在国外认可度还不错，毕竟不靠发review拉分，唯一的就是版面费不便宜，cell press旗下，看好未来！

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216879, encodeId=fddc22168e9e0, content=投了一次，1天拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Thu Jul 25 21:54:18 CST 2024, time=2024-07-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：molecular biology<br>经验分享：难度不低，影响因子不高，不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿，今年1月接收，历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向：肠道微生物与宿主互作<br>经验分享：12月16号投的，23号under review，今天2月14号了，快2个月了，还没有消息，各位一般一审多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向：肿瘤<br>经验分享：文章质量很好，不明白为什么一直上不去10呢？难道是不怎么发综述吗？很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢，编辑态度很好，review意见专业，根据我的经验这个期刊算不上水刊，而且在国外认可度还不错，毕竟不靠发review拉分，唯一的就是版面费不便宜，cell press旗下，看好未来！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省)]
    2023-04-29 ms2000000147841561 来自河北省

    好

    0

共386条页码: 2/39页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分